On February 2, 2005, NIH Director Elias Zerhouni announced an overhaul of agency ethics guidelines that would restrict all 18,000 NIH employees’ outside consulting activities for pharmaceutical companies, hospitals, insurers and health providers “in an effort to restore luster” to NIH’s “tarnished reputation.” Under the revised guidelines, about 6,000 high-ranking NIH employees would no longer […]